Clinical Trial Update: Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer

View source ↗

Summary

An update from Yonsei University investigates how often HER2 is overexpressed in gastric adenocarcinoma and the prognostic effect of HER2 status. It also analyz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Yonsei University | Conditions: Stomach Neoplasms | Status: UNKNOWN